High Prevalence of Vitamin D Deficiency in Patients with Bone Tumors

References

• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S–1086S.
   PubMed Web of Science ®Google Scholar
• Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho JM, Munoz A. Vitamin D and Wnt/beta-catenin pathway in colon cancer: Role and regulation of DICKKOPF genes. Anticancer Res 2008;28:2613–2623.
   PubMed Web of Science ®Google Scholar
• Rohan JN, Weigel NL. 1Alpha, 25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology 2009;150:2046–2054.
   PubMed Web of Science ®Google Scholar
• Cross HS, Lipkin M, Kallay E. Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 2006;136:561–564.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451–459.
   PubMed Web of Science ®Google Scholar
• Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252–261.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014;14:342–357.
   PubMed Web of Science ®Google Scholar
• Tagliabue E, Raimondi S, Gandini S. Vitamin D, Cancer Risk, and Mortality. Adv Food Nutr Res 2015;75:1–52.
   PubMedGoogle Scholar
• McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED, et al. Serum 25-hydroxyvitamin D concentrations > = 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study. PLoS One 2016;11:e0152441.
   PubMed Web of Science ®Google Scholar
• van der Rhee H, Coebergh JW, de Vries E. Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev 2009;18:458–475.
   PubMed Web of Science ®Google Scholar
• Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer–ready for prime time? N Engl J Med 2011;364:1385–1387.
   PubMed Web of Science ®Google Scholar
• Chlebowski RT. Vitamin D and breast cancer incidence and outcome. Anticancer Agents Med Chem 2013;13:98–106.
   PubMed Web of Science ®Google Scholar
• Lauter B, Schmidt-Wolf IG. Prevalence, supplementation, and impact of vitamin D deficiency in multiple myeloma patients. Cancer Invest 2015;33:505–509.
   PubMed Web of Science ®Google Scholar
• Badros A, Goloubeva O, Terpos E, Milliron T, Baer MR, Streeten E. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008;142:492–494.
   PubMed Web of Science ®Google Scholar
• Maier GS, Horas K, Kurth AA, Lazovic D, Seeger JB, Maus U. Prevalence of Vitamin D deficiency in patients with bone metastases and multiple myeloma. Anticancer Res 2015;35:6281–6285.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhou H, Dunstan CR, Sutherland RL, Seibel MJ. The role of the bone microenvironment in skeletal metastasis. J Bone Oncol 2013;2:47–57.
   PubMed Web of Science ®Google Scholar
• Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, et al. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol 2005;23:4925–4935.
   PubMed Web of Science ®Google Scholar
• Churilla TM, Brereton HD, Klem M, Peters CA. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 2012;64:521–525.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhou H, Ooi LL, Snir AD, Dunstan CR, Seibel MJ. Vitamin D deficiency promotes prostate cancer growth in bone. Prostate 2011;71:1012–1021.
   PubMed Web of Science ®Google Scholar
• Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ, et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res 2010;70:1835–1844.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–1930.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Azuma Y, Kiyoki M, Okumura H, Hashimoto K, Yoshikawa K. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Biochim Biophys Acta 1991;1092:311–318.
   PubMed Web of Science ®Google Scholar
• Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, et al. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 2005;11:3579–3586.
   PubMed Web of Science ®Google Scholar
• Gallagher R, Keighley J, Tancabelic J, Garimella R, Pinson D, Templeton K, et al. Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcoma. Ann Diagn Pathol 2012;16:323–329.
   PubMed Web of Science ®Google Scholar
• Thompson L, Wang S, Tawfik O, Templeton K, Tancabelic J, Pinson D, et al. Effect of 25-hydroxyvitamin D3 and 1 alpha,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines. J Orthop Res 2012;30:831–844.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584–593.
   PubMed Web of Science ®Google Scholar
• Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655–1664.
   PubMed Web of Science ®Google Scholar
• Horas K, Zheng Y, Zhou H, Seibel MJ. Animal models for breast cancer metastasis to bone: Opportunities and limitations. Cancer Invest 2015;1–10.
   Web of Science ®Google Scholar
• Hofbauer LC, Rachner TD, Coleman RE, Jakob F. Endocrine aspects of bone metastases. Lancet Diabetes Endocrinol 2014;2:500–512.
   PubMed Web of Science ®Google Scholar
• Ng AC, Kumar SK, Rajkumar SV, Drake MT. Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 200984:397–400.
   PubMed Web of Science ®Google Scholar
• Maier GS, Jakob P, Horas K, Roth KE, Kurth AA, Maus U. Vitamin D deficiency in orthopaedic patients: A single center analysis. Acta Orthop Belg 2013;79:587–591.
   PubMed Web of Science ®Google Scholar
• Maier GS, Horas K, Seeger JB, Roth KE, Kurth AA, Maus U. Vitamin D insufficiency in the elderly orthopaedic patient: An epidemic phenomenon. Int Orthop 2015;39:787–792.
   PubMed Web of Science ®Google Scholar
• Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008;62:1079–1089.
   PubMed Web of Science ®Google Scholar
• Zittermann A. The estimated benefits of vitamin D for Germany. Mol Nutr Food Res 2010;54:1164–1171.
   PubMed Web of Science ®Google Scholar
• Ringe JD, Kipshoven C. Vitamin D-insufficiency: An estimate of the situation in Germany. Dermatoendocrinol 2012;4:72–80.
   PubMedGoogle Scholar
• Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 1997;82:118–122.
   PubMed Web of Science ®Google Scholar